Spago Nanomedical AB (SPAGO) — Cash Flow-to-Debt Ratio

Latest as of December 2025: -1.04x

Spago Nanomedical AB (SPAGO) has a Cash Flow-to-Debt Ratio of -1.04x as of December 2025, meaning its operating cash flow of Skr-6.19 Million could theoretically repay -1% of its total liabilities (Skr5.94 Million) in one year. See Spago Nanomedical AB (SPAGO) flexibility index to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-1.04x
Operating CF / Total Liabilities

Operating Cash Flow

Skr-6.19 Million
SEK

Total Liabilities

Skr5.94 Million
SEK

Data as of

Dec 2025
Most recent filing

Spago Nanomedical AB Cash Flow-to-Debt Ratio (2011–2025)

Historical debt coverage capacity for Spago Nanomedical AB across 15 annual periods. For the full cash flow conversion analysis, see Spago Nanomedical AB (SPAGO) cash flow conversion.

Annual Cash Flow-to-Debt Ratio for Spago Nanomedical AB (2011–2025)

Year-by-year debt coverage analysis for Spago Nanomedical AB.

Year CF-to-Debt Ratio Operating CF (SEK) Total Liabilities YoY Change
2025 -4.77x Skr-28.30 Million Skr5.94 Million ▲ +12.7%
2024 -5.46x Skr-34.67 Million Skr6.35 Million ▼ -41.9%
2023 -3.85x Skr-44.91 Million Skr11.67 Million ▲ +11.3%
2022 -4.34x Skr-38.19 Million Skr8.80 Million ▲ +16.9%
2021 -5.22x Skr-35.57 Million Skr6.81 Million ▲ +12.5%
2020 -5.97x Skr-18.77 Million Skr3.15 Million ▲ +18.5%
2019 -7.32x Skr-21.29 Million Skr2.91 Million ▼ -185.3%
2018 -2.57x Skr-10.51 Million Skr4.10 Million ▼ -26.5%
2017 -2.03x Skr-7.73 Million Skr3.81 Million ▼ -112.0%
2016 -0.96x Skr-7.86 Million Skr8.22 Million ▼ -67.0%
2015 -0.57x Skr-5.34 Million Skr9.33 Million ▼ -88.0%
2014 -0.30x Skr-5.95 Million Skr19.53 Million ▲ +22.4%
2013 -0.39x Skr-7.74 Million Skr19.69 Million ▼ -642.6%
2012 -0.05x Skr-601.00K Skr11.36 Million ▼ -138.2%
2011 -0.02x Skr-276.00K Skr12.42 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.